中国科技核心期刊
中国科技论文统计源期刊
中文生物医学期刊文献数据库
中国科学引文数据库(CSCD收录)
中国学术期刊综合评价数据库统计源期刊
《中国学术期刊影响因子年报》统计源期刊
Chinese Journal of Blood Purification ›› 2013, Vol. 12 ›› Issue (11): 602-604.doi: 10.3969/j.issn.1671-4091.2013.11.00
Previous Articles Next Articles
Received:
Revised:
Online:
Published:
Abstract: [Abstract]:OBJECTIVE To determine whether 1% Cefazolin-30% sodium citrate prevents the catheter-related bacteremia and influences the incidence of the dysfunction of catheter.METHODS A randomized prospective controlled study was undertaken.25 hemodialysis patients were randomly divided into two groups,13 of group patients receive 1% Cefazolin-30% sodium citrate into each lumen of the catheter three times a week,12 of control group patients receive heparin locks only three times a week for 6 months.The incidence rates of the catheter-related bacteremia,the catheter dysfunction,and other adverse reactions were recorded. RESULTS The incidence of catheter-related bacteremia was 0.85/1000 catheter days in the group and 2.29/1000 catheter days in the control group, The incidence of catheter dysfunction was 1.17% in the group and 2.87% in the control group, The incidence of catheter-related bacteremia and catheter dysfunction between the two groups was statistically significant(p<0.01).The serum Ca2+、Mg2+、ALT、AST between the two groups showed no obvious changes before and after treatment(p>0.05).The main side effect in the group was 4.2‰,the symptom was spontaneous remission.CONCLUSION As compare with the heparin catheter locks, 1% Cefazolin-30% sodium citrate can effectively reduce the catheter-related bacteremia and catheter dysfunction,and it was safer.
Key words: [key words] Cefazolin, sodium citrate, hemodialysis, long-term indwelling catheter
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: https://www.cjbp.org.cn/EN/10.3969/j.issn.1671-4091.2013.11.00
https://www.cjbp.org.cn/EN/Y2013/V12/I11/602